SENS - Senseonics Holdings, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Senseonics Holdings, Inc.
Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients.
IPO Date: February 22, 2000
Sector: Healthcare
Industry: Medical Diagnostics and Research
Market Cap: $484.33M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.10 | 4.33%
Avg Daily Range (30 D): $0.26 | 2.69%
Avg Daily Range (90 D): $0.24 | 3.20%
Institutional Daily Volume
Avg Daily Volume: 5.09M
Avg Daily Volume (30 D): .55M
Avg Daily Volume (90 D): .57M
Trade Size
Avg Trade Size (Sh.): 448
Avg Trade Size (Sh.) (30 D): 78
Avg Trade Size (Sh.) (90 D): 81
Institutional Trades
Total Institutional Trades: 483
Avg Institutional Trade: $2.01M
Avg Institutional Trade (30 D): $1.3M
Avg Institutional Trade (90 D): $1.72M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.13M
Avg Closing Trade (30 D): $1.29M
Avg Closing Trade (90 D): $1.88M
Avg Closing Volume: 113.32K
 
News
Sep 29, 2026 @ 2:06 PM
Beta Bionics Stock Down Despite iLet-Eversense 365...
Source: Na
Jul 14, 2026 @ 4:30 AM
Global Blood Glucose Monitoring System Market Size...
Source: Custom Market Insights
May 1, 2026 @ 1:50 AM
Senseonics Announces Pricing of $80 Million Public...
Source: Na
Apr 29, 2026 @ 8:31 AM
Middle East and Africa Continuous Glucose Monitori...
Source: Researchandmarkets.Com
Apr 24, 2026 @ 11:00 AM
Senseonics Announces European Launch of EversenseÃ...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-2.24 $-.63 $-.71
Diluted EPS $-2.24 $-.63 $-.71
Revenue $48.55M $14.48M $11.71M
Gross Profit $26.64M $8.56M $6.94M
Net Income / Loss $-109.39M $-36.71M $-32.33M
Operating Income / Loss $-108.36M $-35.99M $-31.85M
Cost of Revenue $21.91M $5.92M $4.77M
Net Cash Flow $13.24M $15.14M $-10.62M
PE Ratio    
Splits
Oct 20, 2025 1:20
Nov 10, 2015 12:1